Kelly Jason R 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:03 pm Sale |
2024-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Kelly Jason R | 2,143,808 5.000% |
-281,628 (-11.61%) |
Filing |
| 2023-01-24 8:19 pm Sale |
2023-01-24 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Kelly Jason R | 2,425,436 6.200% |
-271,324 (-10.06%) |
Filing |
| 2022-10-04 9:51 pm Purchase |
2022-10-01 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Kelly Jason R | 2,696,759 8.500% |
632,232 (+30.62%) |
Filing |
| 2021-09-27 5:23 pm Purchase |
2021-09-16 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Kelly Jason R | 2,064,528 5.800% |
2,064,528 (New Position) |
Filing |